Suppr超能文献

不可切除性恶性肠梗阻的预后因素

Outcome prognostic factors in inoperable malignant bowel obstruction.

作者信息

Romeo Margarita, de Los LLanos Gil Maria, Cuadra Urteaga José Luís, Vilà Laia, Ahlal Sara, Indacochea Alberto, Pardo Núria, Radua Joaquim, Font Albert, Tuca Albert

机构信息

Medical Oncology Department, Institut Català d'Oncologia, Carretera del Canyet s/n, 08916, Badalona, Spain.

Universitat Autónoma de Barcelona, Barcelona, Spain.

出版信息

Support Care Cancer. 2016 Nov;24(11):4577-86. doi: 10.1007/s00520-016-3299-7. Epub 2016 Jun 10.

Abstract

PURPOSE

Inoperable malignant bowel obstruction (MBO), a severe complication of peritoneal carcinomatosis, has a low desobstruction rate (30-40 %) and end-of-life decision-making is hampered by the lack of known prognostic factors. This study aimed to explore prognostic factors for desobstruction in MBO.

METHODS

All patients with inoperable MBO admitted in our large oncology hospital between 2010 and 2013 were treated following a clinical protocol based on antiemetics, steroids and two antisecretories, octreotide, and hyoscine butylbromide. Two prognostic factor analyses using logistic regressions were performed, one based on data from day 1 of admission and the other on data from day 8.

RESULTS

Forty-five patients were included. Frequency of desobstruction was 48.9 %. In the analysis of prognostic factors on day 1, MBO episodes derived from functional physiopathologic mechanisms (vs. mechanic or mixed) were more prone to resolve (p < 0.001 corrected for multiple comparisons). Considering patients alive with persistent obstruction on day 8, a better clinical condition was the variable more associated with desobstruction, but without statistical significance after correction for multiple comparisons.

CONCLUSIONS

A functional physiopathologic mechanism of MBO development may be an early prognostic factor for desobstruction. A high proportion of desobstruction was observed, suggesting that the combination of antisecretories with different mechanism of action warrants further investigation.

摘要

目的

不可手术切除的恶性肠梗阻(MBO)是腹膜癌病的一种严重并发症,解除梗阻率较低(30%-40%),且由于缺乏已知的预后因素,临终决策受到阻碍。本研究旨在探讨MBO解除梗阻的预后因素。

方法

2010年至2013年期间入住我们大型肿瘤医院的所有不可手术切除的MBO患者均按照基于止吐药、类固醇和两种抗分泌药(奥曲肽和丁溴东莨菪碱)的临床方案进行治疗。使用逻辑回归进行了两项预后因素分析,一项基于入院第1天的数据,另一项基于第8天的数据。

结果

纳入45例患者。解除梗阻的频率为48.9%。在第1天的预后因素分析中,源于功能性生理病理机制(相对于机械性或混合性)的MBO发作更易于缓解(经多重比较校正后p<0.001)。考虑到第8天仍有持续性梗阻的存活患者,较好的临床状况是与解除梗阻关联度更高的变量,但经多重比较校正后无统计学意义。

结论

MBO发生的功能性生理病理机制可能是解除梗阻的早期预后因素。观察到较高比例的解除梗阻情况,提示作用机制不同的抗分泌药联合使用值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验